Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
Abroad (travel likely)RecruitingPHASE4
Conditions
Cytomegalovirus · Organ Transplant · Kidney Transplant; Complications · Liver Transplant Complications · Simultaneous Liver-Kidney Transplantation; Complications
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (MGH Abdominal Transplant Unit) · TransplantResearchUnit@MassgeneralBrigham.org · 617-643-4087Contact: Principal Investigator (Camille Kotton, MD)University of Texas Southwestern, Dallas, Texas, United States
Contact: Study coordinator (Jarrett Hubbard, BA) · Jarrett.Hubbard@UTSouthwestern.edu · 214-648-3111Contact: Study coordinator (David Wojciechowski, DO) · David.Wojciechowski@UTSouthwestern.edu · (214) 648-3111Contact: Principal Investigator (David Wojciechowski, DO)
Study leads
Camille Kotton, MD, FIDSA, FAST
Principal Investigator
Massachusetts General Hospital
David Wojciechowski, DO
Principal Investigator
University of Texas Southwestern Medical Center